Re: BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic
The pressure on management to create revenue is in place. Cleveland Clinic joins with HCA and Mayo as placements with multi-state conglomerates. No More Freebies should be the rule and the 60-day period should be in stone.
What baffles me is where is the $150,000 per unit revenue from the first ?20? placements (three million in sales). Revenue collected since product approval thus far is $449K. It is reasonable to give Mayo and U.T.@St. David a sweet deal but management should have either sold or picked up the units at the other 18 locations. The rate of use seems to have slowed, rather than accelerated (approx. 200 per quarter vs. 1700 for the first nine months of 2021). Maybe some were picked up?
I'll continue to hold to the 3rd quarter conference call. We have a second, official launch in place effective July 1st under new sales management (Access Strategy last winter as the first). I remain to like the tech potential. The prospect of a de-listing is growing (sub $1 rule) ... will arm the short programs. All the best.